We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
It’s easy to understand why dividends are so cherished among investors, as they provide a passive income stream, help limit the impact of drawdowns in other positions, and allow for maximum returns through dividend reinvestment.
In addition, a company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. And, of course, dividend boosts help send a positive message surrounding the long-term picture of the company, instilling confidence it can withstand near-term uncertainties or challenges.
Three companies – Enterprise Product Partners (EPD - Free Report) , Abbott Laboratories (ABT - Free Report) , and Broadcom (AVGO - Free Report) – have all grown their payouts nicely.
For those seeking dividend-growers, let’s take a closer look at each.
Enterprise Product Partners
Enterprise Products Partners is a partnership that provides services to producers and consumers of commodities, including natural gas, natural gas liquids, oil, and refined petrochemical products.
Interestingly enough, in December, A.J. Teague, co-CEO, purchased roughly 2400 EPD shares at a total transaction value just above $65k. Insider buys can further inject confidence into shareholders.
EPD recently announced a 3% boost to its quarterly payout, bringing it to $2.06 annually. The company has consistently increasingly rewarded its shareholders throughout the years, as seen in the chart below.
Image Source: Zacks Investment Research
And perhaps to the surprise of some, EPD shares have displayed a small level of relative strength over the last month, adding +2.6% compared to the S&P 500’s 1.7% gain. While the performance disparity isn’t large, it’s certainly worth keeping tabs on.
Image Source: Zacks Investment Research
Broadcom
Broadcom is a premier designer, developer, and global supplier of a broad range of semiconductor devices. The revisions trend has been particularly potent for its current fiscal year, with the $47.88 Zacks Consensus EPS Estimate 11% higher over the last year.
Image Source: Zacks Investment Research
Broadcom has shown a notable commitment to increasingly rewarding shareholders, boasting a sizable 13.7% five-year annualized dividend growth rate. AVGO shares currently yield a solid 2% annually, nicely above the Zacks Computer and Technology sector average of 0.7%.
Image Source: Zacks Investment Research
Impressive cash-generating abilities have protected the company’s payout, further illustrated below. AVGO posted free cash flow of $16.3 billion throughout its FY22, with the trailing twelve-month figure eclipsing $17.6 billion.
Image Source: Zacks Investment Research
Abbott Laboratories
Abbott Labs discovers, develops, manufactures, and sells a diversified line of healthcare products. The company is a part of the elite Dividend Aristocrats group, a club reserved for those who have upped their payouts for 25+ consecutive years.
Image Source: Zacks Investment Research
Keep an eye out for the company’s upcoming release expected in late January, as the Zacks Consensus EPS Estimate of $1.19 suggests growth of 15% from the year-ago period. It’s worth noting that ABT has been a highly consistent earnings performer, exceeding our consensus EPS and revenue expectations in each of its last ten releases.
Bottom Line
Companies that consistently boost their dividend payouts reflect a successful and shareholder-friendly nature, opting to share a portion of profits with investors.
And for those seeking dividend growers, all three companies above – Enterprise Product Partners (EPD - Free Report) , Abbott Laboratories (ABT - Free Report) , and Broadcom (AVGO - Free Report) – precisely fit the criteria.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
3 Dividend Growers Suited for Income Investors
It’s easy to understand why dividends are so cherished among investors, as they provide a passive income stream, help limit the impact of drawdowns in other positions, and allow for maximum returns through dividend reinvestment.
In addition, a company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. And, of course, dividend boosts help send a positive message surrounding the long-term picture of the company, instilling confidence it can withstand near-term uncertainties or challenges.
Three companies – Enterprise Product Partners (EPD - Free Report) , Abbott Laboratories (ABT - Free Report) , and Broadcom (AVGO - Free Report) – have all grown their payouts nicely.
For those seeking dividend-growers, let’s take a closer look at each.
Enterprise Product Partners
Enterprise Products Partners is a partnership that provides services to producers and consumers of commodities, including natural gas, natural gas liquids, oil, and refined petrochemical products.
Interestingly enough, in December, A.J. Teague, co-CEO, purchased roughly 2400 EPD shares at a total transaction value just above $65k. Insider buys can further inject confidence into shareholders.
EPD recently announced a 3% boost to its quarterly payout, bringing it to $2.06 annually. The company has consistently increasingly rewarded its shareholders throughout the years, as seen in the chart below.
Image Source: Zacks Investment Research
And perhaps to the surprise of some, EPD shares have displayed a small level of relative strength over the last month, adding +2.6% compared to the S&P 500’s 1.7% gain. While the performance disparity isn’t large, it’s certainly worth keeping tabs on.
Image Source: Zacks Investment Research
Broadcom
Broadcom is a premier designer, developer, and global supplier of a broad range of semiconductor devices. The revisions trend has been particularly potent for its current fiscal year, with the $47.88 Zacks Consensus EPS Estimate 11% higher over the last year.
Image Source: Zacks Investment Research
Broadcom has shown a notable commitment to increasingly rewarding shareholders, boasting a sizable 13.7% five-year annualized dividend growth rate. AVGO shares currently yield a solid 2% annually, nicely above the Zacks Computer and Technology sector average of 0.7%.
Image Source: Zacks Investment Research
Impressive cash-generating abilities have protected the company’s payout, further illustrated below. AVGO posted free cash flow of $16.3 billion throughout its FY22, with the trailing twelve-month figure eclipsing $17.6 billion.
Image Source: Zacks Investment Research
Abbott Laboratories
Abbott Labs discovers, develops, manufactures, and sells a diversified line of healthcare products. The company is a part of the elite Dividend Aristocrats group, a club reserved for those who have upped their payouts for 25+ consecutive years.
Image Source: Zacks Investment Research
Keep an eye out for the company’s upcoming release expected in late January, as the Zacks Consensus EPS Estimate of $1.19 suggests growth of 15% from the year-ago period. It’s worth noting that ABT has been a highly consistent earnings performer, exceeding our consensus EPS and revenue expectations in each of its last ten releases.
Bottom Line
Companies that consistently boost their dividend payouts reflect a successful and shareholder-friendly nature, opting to share a portion of profits with investors.
And for those seeking dividend growers, all three companies above – Enterprise Product Partners (EPD - Free Report) , Abbott Laboratories (ABT - Free Report) , and Broadcom (AVGO - Free Report) – precisely fit the criteria.